Givaudan reported 306M in Cash and Equivalent for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Akzo Nobel AKZA:NA € 1216M 19M
Arkema AKE:FP € 2415M 921M
BASF BAS:GR € 2869M 1258M
Bayer BAYN:GR € 3389M 2161M
British American Tobacco BATS:LN 3.01B 125M
Covestro 1COV:GR 856M 1.25B
Croda International CRDA:LN 104.8M 1.7M
Diageo DGE:LN 2.75B 14M
DSM DSM:NA € 871M 815M
Fresenius FRE:GR € 2250M 373M
Fresenius Medical Care FME:GR € 1408M 335M
Givaudan GIVN:VX 306M 105M
Glanbia GLB:ID 156.6M 7.7M
International Flavors Fragrances IFF:US $ 935M 63M
Johnson Matthey JMAT:LN 581M 189M
Lonza Group LONN:SW 501M 6M
Merck MRK:GR € 1825M 413M
SGS SGSN:VX 1.17B 597M
Solvay SOLB:BB € 1216M 71M
Tate & Lyle TATE:LN 371M 113M
Umicore UMI:BB 1.19B 178.59M